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0051: TO EVALUATE THE EFFECT OF HYPERBARIC OXYGEN THERAPY ON
THE HEARING OUTCOME IN PATIENTS WITH SUDDEN SENSORINEURAL
HEARING LOSS
S. Agrawal*, N. Sharma, N. Banerjee. PGIMER & Dr. Ram Manohar Lohia
Hospital, India
Aim: To ascertain whether the addition of HBOT to conventional medical
treatment improves hearing outcome in patients with Sudden SNHL, to
assess the impact of patient-related and audio vestibular parameters on
prognosis, to document any adverse effects of HBOT.
Methods: 40 patients with Sudden SNHL, 18e60 years, were enrolled. 20
patients (Group A) received steroids, plasma expander, gingko biloba,
nicotinic acid, betahistine, and antiviral. 20 patients (Group B) received the
above with HBOT (10 sessions). Audiological assessments were performed
with pure tone audiometry on day 5,10,at each month's end, for 3 months.
Following parameters were noted: demographics (age, gender); tinnitus;
vertigo; time between onset of loss and initiation of treatment; severity of
hearing loss. Hearing outcomes were evaluated by four indices: cure rate,
marked recovery rate, recovery rate, and hearing gain.
Results:Mean hearing gainwas 31.5 + 20.0 dB inGroupB,whichwas higher
than in Group A,16.8 + 17.5 dB(p¼ 0.018). Marked recovery ratewas higher
in Group B(50%vs20%; p¼ 0.047).Patients treated within ﬁrst seven days of
onset showed higher hearing gains and marked recovery rates. Cure rate
was higher in patients without vertigo (19%vs0%; p ¼ 0.045).20%patients
suffered from adverse effects of HBOT, most common being otitis media.
Conclusion: Addition of HBOT to conventional treatment signiﬁcantly
improves the outcome of sudden deafness; its use should be encouraged as
an adjunctive therapy. Age, gender, tinnitus, severity of hearing loss did not
affect the outcome of sudden hearing loss. Presence of vertigo and initia-
tion of treatment more than seven days after onset were poor prognostic
factors. HBOT was a relatively benign intervention.0152: ANALYSIS OF PRO [-2] PSA: A NOVEL BIOMARKER THAT
SIGNIFICANTLY IMPROVES THE DETECTION OF PROSTATE CANCER
R. Foley 1,*, L. Gorman 1, D. Lundon 2, N. Shariﬁ 3, K. Murphy 1, A.
Tuzova 4, A. Perry 4, T.B. Murphy 1, R.W. Watson 1. 1University College* Corresponding author.
http://dx.doi.org/10.1016/j.ijsu.2015.07.017Dublin, Ireland; 2Mater Misericordiae University Hospital, Ireland;
3Beaumont Hospital, Ireland; 4 Trinity College, Ireland
Aim: In order to effectively select patients for prostate biopsy more
accurate biomarkers of disease are needed. The objective of this study
was to analyse the clinical utility of a novel biomarker; pro [-2] PSA in
order to inform the decision for prostate biopsy in an Irish cohort of
men.
Methods: The serum of 250 men from three tertiary referral centres with
pre-biopsy blood draws was analysed for tPSA, fPSA and pro [-2] PSA. From
this the phi score was calculated (pro [-2] PSA/fPSA)*√tPSA). Calibration
plots, ROC analysis as well as decision curve analysis were utilised to
ascertain the potential utility of the phi score.
Results: The phi score was well calibrated in this cohort demonstrating
good correlation between predicted probabilities and actual outcome. The
AUC for the phi score was 0.72 for the prediction of prostate cancer and
0.78 for the prediction of high grade prostate cancer (gleason  7),
compared to 0.62 and 0.70 for tPSA. Decision curve analysis demon-
strated net beneﬁt of the phi score over its entire range of risk
probabilities.
Conclusion: The measurement of pro [-2] PSA can increase the accuracy of
risk calculation in each individual patient thereby helping to better inform
the decision for prostate biopsy in a referral population.0334: OPTIMISATION OF BIOMATERIAL SURFACES FOR NEXT
GENERATION NEUROSURGICAL IMPLANTS
R. Bartlett*, B. Cousins. University College London, UK
Aim: Neurosurgically implanted electrical devices are used to treat a
range of severely debilitating disorders. However, their current use is
limited by poor long-term biocompatibility, and thus this research aimed
to investigate whether chemical modiﬁcation was useful strategy in
overcoming this.
Methods: Glass and gold substrates were chemically modiﬁed using
organosilane precursors to produce either methyl (eCH3), amine (eNH2)
or thiol (eSH) functionalised surfaces. Contact angle (q) measurements
were performed to validate the modiﬁcation process and PC-12 cells
cultured. Light microscopy and SEM provided information on cell behav-
iour, whilst cell-based assays were used to quantify metabolic activity and
proliferation.
Results: Thiol functionalised surfaces were found to confer signiﬁcantly
greater levels of cell adhesion (p ¼ 0.005), proliferation (p < 0.001),
